INS and metabolic dysfunction-associated steatotic liver disease: A number of studies [17–19] conducted in NAFLD patients have shown both an impaired ability of insulin to suppress endogenous glucose production, indicating the presence of hepatic insulin resistance, and an approximately 50% reduction in glucose disposal, a measure of whole-body insulin sensitivity.